tangeretin has been researched along with cyclic gmp in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canada, AT; Nguyen, TD | 1 |
Ali, MS; Gibbins, JM; Jones, CI; Lewis, KR; Moraes, LA; Sage, T; Vaiyapuri, S | 1 |
2 other study(ies) available for tangeretin and cyclic gmp
Article | Year |
---|---|
Citrus flavonoids stimulate secretion by human colonic T84 cells.
Topics: Adenocarcinoma; Carbachol; Chlorides; Citrus; Colon; Colonic Neoplasms; Cyclic AMP; Cyclic GMP; Drug Synergism; Flavanones; Flavones; Flavonoids; Glycosylation; Humans; Kinetics; Tumor Cells, Cultured | 1993 |
Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
Topics: Animals; Blood Platelets; Calcium Signaling; Cell Adhesion Molecules; Cyclic GMP; Dose-Response Relationship, Drug; Flavones; Hemostasis; Humans; Mice; Mice, Inbred C57BL; Microfilament Proteins; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Second Messenger Systems; Thrombosis; Time Factors | 2013 |